Based on critical analyses of the costs of drugs in Canada, researchers from six universities, including ÐÓ°ÉÔ­´´’s M-A. Gagnon, released their report . An editorial in the notes that the best reason for a national pharmacare plan is “about giving all Canadians fair and equitable access to medicines they need — drugs that work to keep them healthy, ease their pain, and save their lives”.